| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1996PNAS...93.7242S |
| P356 | DOI | 10.1073/PNAS.93.14.7242 |
| P932 | PMC publication ID | 38967 |
| P698 | PubMed publication ID | 8692976 |
| P5875 | ResearchGate publication ID | 14509233 |
| P2093 | author name string | Ohashi K | |
| Ishibashi S | |||
| Harada K | |||
| Yamada N | |||
| Shimada M | |||
| Inaba T | |||
| Yazaki Y | |||
| Yagyu H | |||
| Osuga JI | |||
| P2860 | cites work | Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein | Q24561866 |
| A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia | Q28291035 | ||
| Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice | Q28505210 | ||
| Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells | Q28509783 | ||
| Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery | Q29615235 | ||
| Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E | Q29615236 | ||
| The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis | Q34113923 | ||
| Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice | Q34142722 | ||
| Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall | Q34198863 | ||
| Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension | Q34204885 | ||
| Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix | Q35597206 | ||
| Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques | Q35602166 | ||
| Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages | Q35607180 | ||
| Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey | Q35810040 | ||
| Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans | Q36256135 | ||
| Quantitative assessment of atherosclerotic lesions in mice | Q36456167 | ||
| Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions | Q37620050 | ||
| Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases | Q38611172 | ||
| Fibric acids: effects on lipids and lipoprotein metabolism | Q39683087 | ||
| A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins | Q39900438 | ||
| High density lipoprotein metabolism. | Q40197261 | ||
| Expression of lipoprotein lipase mRNA and secretion in macrophages isolated from human atherosclerotic aorta | Q40305289 | ||
| Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein | Q40341402 | ||
| Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. | Q41164669 | ||
| The role of lipoprotein lipase in the metabolism of triglyceride-rich lipoproteins by macrophages. | Q41920898 | ||
| Modification of low density lipoprotein by lipoprotein lipase or hepatic lipase induces enhanced uptake and cholesterol accumulation in cells | Q41947019 | ||
| Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events | Q43891430 | ||
| Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. | Q46734243 | ||
| Regulation by nutritional status of lipids and apolipoproteins A-I, A-II, and A-IV in inbred mice. | Q51597405 | ||
| A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis | Q57840099 | ||
| Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein | Q59070155 | ||
| Post delivery care of the edentulous geriatric patient | Q66854539 | ||
| Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans | Q67852238 | ||
| Apolipoprotein E and lipoprotein lipase secreted from human monocyte-derived macrophages modulate very low density lipoprotein uptake | Q68708728 | ||
| Variation in susceptibility to atherosclerosis among inbred strains of mice | Q69805944 | ||
| Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men | Q69901677 | ||
| Rapid genotyping of low density lipoprotein receptor knockout mice using a polymerase chain reaction technique | Q70893238 | ||
| Overexpression of human lipoprotein lipase enhances uptake of lipoproteins containing apolipoprotein B-100 in transfected cells | Q72767044 | ||
| Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia | Q72875879 | ||
| Atherogenic lipoproteins and coronary artery disease: concepts derived from recent advances in cellular and molecular biology | Q93612468 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipoprotein | Q28350 |
| knockout mouse | Q1364740 | ||
| atherosclerosis | Q12252367 | ||
| overexpression | Q61643320 | ||
| P1104 | number of pages | 5 | |
| P304 | page(s) | 7242-7246 | |
| P577 | publication date | 1996-07-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase | |
| P478 | volume | 93 |
| Q28589301 | A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice |
| Q22009153 | A novel endothelial-derived lipase that modulates HDL metabolism |
| Q40201352 | Accelerated atherosclerosis development in C57Bl6 mice by overexpressing AAV-mediated PCSK9 and partial carotid ligation |
| Q44016842 | Activity and concentration of lipoprotein lipase in post-heparin plasma and the extent of coronary artery disease |
| Q45365704 | Adeno-associated virus-mediated expression of acid sphingomyelinase decreases atherosclerotic lesion formation in apolipoprotein E(-/-) mice |
| Q35852316 | An Atherogenic Paigen-Diet Aggravates Nephropathy in Type 2 Diabetic OLETF Rats |
| Q37383956 | Cholesterol lowering in low density lipoprotein receptor knockout mice overexpressing apolipoprotein E. |
| Q64069044 | Crude α-Mangostin Suppresses the Development of Atherosclerotic Lesions in -Deficient Mice by a Possible M2 Macrophage-Mediated Mechanism |
| Q53757035 | Daily supplementation with fresh pomegranate juice increases paraoxonase 1 expression and activity in mice fed a high-fat diet. |
| Q46418731 | Differential effects of lipoprotein lipase on tumor necrosis factor-alpha and interferon-gamma-mediated gene expression in human endothelial cells |
| Q35895453 | Discovery and validation of new molecular targets in treating dyslipidemia: the role of human genetics |
| Q48182034 | Elevated plasma cholesterol does not affect brain Abeta in mice lacking the low-density lipoprotein receptor |
| Q38988355 | Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases |
| Q35692015 | Endothelial lipase and cholesterol metabolism |
| Q34829121 | Endothelial lipase is a major determinant of HDL level |
| Q39180867 | Functional Roles of the Interaction of APP and Lipoprotein Receptors. |
| Q34107177 | Gene therapy for dyslipidemia: clinical prospects |
| Q33877037 | Genes influencing HDL metabolism: new perspectives and implications for atherosclerosis prevention |
| Q34107511 | High-density lipoprotein metabolism: molecular targets for new therapies for atherosclerosis |
| Q35776630 | Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion |
| Q33822096 | Incremental replacement of saturated fats by n-3 fatty acids in high-fat, high-cholesterol diets reduces elevated plasma lipid levels and arterial lipoprotein lipase, macrophages and atherosclerosis in LDLR-/- mice |
| Q37441271 | Inflammation associated with the postprandial lipolysis of triglyceride-rich lipoproteins by lipoprotein lipase |
| Q34594298 | Lipases and HDL metabolism |
| Q34808268 | Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase |
| Q62023749 | Lipoprotein Lipase (LPL) Strongly Links Native and Oxidized Low Density Lipoprotein Particles to Decorin-coated Collagen |
| Q38322342 | Lipoprotein lipase and angiopoietin-like 4 - Cardiomyocyte secretory proteins that regulate metabolism during diabetic heart disease |
| Q30820478 | Lipoprotein lipase, a key role in atherosclerosis? |
| Q35104848 | Liver X Receptor Signaling Pathways in Cardiovascular Disease |
| Q36709603 | Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity |
| Q28588806 | Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice |
| Q33853087 | Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo |
| Q36039213 | MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice |
| Q38125279 | Molecular biology of atherosclerosis |
| Q40608671 | Molecular cloning of nonsecreted endothelial cell-derived lipase isoforms |
| Q46959635 | Murine mentors: transgenic and knockout models of surgical disease |
| Q44683448 | Overexpression of lipoprotein lipase in transgenic Watanabe heritable hyperlipidemic rabbits improves hyperlipidemia and obesity. |
| Q43690445 | Overexpression of lipoprotein lipase in transgenic rabbits inhibits diet-induced hypercholesterolemia and atherosclerosis |
| Q44879920 | Overexpression of lipoprotein lipase in transgenic rabbits leads to increased small dense LDL in plasma and promotes atherosclerosis. |
| Q44287744 | Phospholipid and cholesteryl ester transfer are increased in lipoprotein lipase deficiency |
| Q44317896 | Plasma concentrations of LPL and LCAT are in putative association with females and alcohol use which are independent negative risk factors for coronary atherosclerosis among Japanese |
| Q33597635 | Receptor-mediated mechanisms of lipoprotein remnant catabolism |
| Q44406171 | Serum concentrations of remnant-like particles in hypothyroid patients before and after thyroxine replacement |
| Q37387115 | The combined role of P- and E-selectins in atherosclerosis |
| Q34986358 | The liver X receptor gene team: potential new players in atherosclerosis |
| Q42437583 | Transgenic rabbits expressing human lipoprotein lipase |
| Q37801785 | Update on the Role of Endothelial Lipase in High-Density Lipoprotein Metabolism, Reverse Cholesterol Transport, and Atherosclerosis |
| Q91984683 | Which is the Best Predictor for the Development of Atherosclerosis Among Circulating Lipoprotein Lipase, Hepatic Lipase, and Endothelial Lipase? |
Search more.